Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2025-12-24 @ 6:29 PM
NCT ID: NCT06267768
Eligibility Criteria: Recruitment of participants after a stroke: The inclusion criteria are: * clinical diagnosis of ischemic and/or hemorrhagic stroke. * age ≥ 18 years. * duration of stroke ranges from 1 month to 12 months after diagnosis. * had no facial palsy, which could prevent proper labial occlusion. * had not undergone thoracic or abdominal surgery. * could understand and follow the verbal instruction. * stable cardiac conditions. * no previous history of respiratory problems. The exclusion criteria are: * acute myocardial infarction or acute heart failure. * acute pain on chest or abdominal. * with the clinical signs of significant pulmonary disease. * consciousness impaired. * patient with nasal feeding tube, tracheal tube and/or any condition, which prevent the measurement or training. Recruitment of healthy participants: The inclusion criteria are: * age ≥ 18 years. * had not undergone thoracic or abdominal surgery. * no previous history of respiratory problems. The exclusion criteria are: * acute myocardial infarction or acute heart failure. * acute pain in the chest or abdominal. * with the clinical signs of significant pulmonary disease. * unstable hypertension, arrhythmias, or unstable cardiovascular conditions, such as fluctuations in blood pressure and heart rate, indicate poor cardiac prognosis or the need for vasopressor medications. * pregnant.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT06267768
Study Brief:
Protocol Section: NCT06267768